KENNETH BATE Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for KENNETH BATE.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of KENNETH BATE. KENNETH BATE is EVP; Chief Financial Officer in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and ExecVP; Head of Commercial Ops in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and Director in AVEO PHARMACEUTICALS INC ($AVEO) and Director in Vanda Pharmaceuticals Inc. ($VNDA) and Director in CATABASIS PHARMACEUTICALS INC ($CATB) and Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and Director in Epizyme, Inc. ($EPZM).

Latest Insider Trading Transactions of KENNETH BATE

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AVEO, BMRN, CATB, EPZM, GNCA, SNTA, MLNM, VNDA

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 02 2021	CATB	CATABASIS PHARMACE ...	BATE KENNETH	Director	Option Exercise	A	2.04	100,000	204,000	100,000
Jun 30 2020	AVEO	AVEO PHARMACEUTICA ...	BATE KENNETH	Director	Option Exercise	A	7.52	4,000	30,080	4,000
Jun 19 2020	GNCA	GENOCEA BIOSCIENCE ...	BATE KENNETH	Director	Option Exercise	A	2.22	15,000	33,300	15,000
Jun 18 2020	SNTA	MADRIGAL PHARMACEU ...	BATE KENNETH	Director	Option Exercise	A	111.06	6,000	666,360	6,000
Jun 12 2020	CATB	CATABASIS PHARMACE ...	BATE KENNETH	Director	Option Exercise	A	6.17	7,500	46,275	7,500
Jun 02 2020	EPZM	Epizyme, Inc.	BATE KENNETH	Director	Option Exercise	A	17.55	14,013	245,928	14,013
Jul 19 2019	GNCA	GENOCEA BIOSCIENCE ...	BATE KENNETH	Director	Option Exercise	A	3.66	5,625	20,588	5,625
Jul 01 2019	SNTA	MADRIGAL PHARMACEU ...	BATE KENNETH	Director	Option Exercise	A	100.45	10,000	1,004,500	10,000
Jun 13 2019	AVEO	AVEO PHARMACEUTICA ...	BATE KENNETH	Director	Option Exercise	A	0.76	40,000	30,400	40,000
Jun 07 2019	EPZM	Epizyme, Inc.	BATE KENNETH	Director	Option Exercise	A	13.74	17,633	242,277	17,633
Jun 05 2019	CATB	CATABASIS PHARMACE ...	BATE KENNETH	Director	Option Exercise	A	6.53	7,500	48,975	7,500
Jun 25 2018	GNCA	GENOCEA BIOSCIENCE ...	BATE KENNETH	Director	Option Exercise	A	0.99	45,000	44,550	45,000
Jun 21 2018	SNTA	MADRIGAL PHARMACEU ...	BATE KENNETH	Director	Option Exercise	A	303.79	10,000	3,037,900	10,000
Jun 21 2018	SNTA	MADRIGAL PHARMACEU ...	BATE KENNETH	Director	Option Exercise	A	303.79	10,000	3,037,900	10,000
Jun 19 2018	AVEO	AVEO PHARMACEUTICA ...	BATE KENNETH	Director	Option Exercise	A	2.27	40,000	90,800	40,000
Jun 07 2018	CATB	CATABASIS PHARMACE ...	BATE KENNETH	Director	Option Exercise	A	1.48	14,000	20,720	14,000
May 31 2018	EPZM	Epizyme, Inc.	BATE KENNETH	Director	Option Exercise	A	17.00	12,500	212,500	12,500
Jul 28 2017	CATB	CATABASIS PHARMACE ...	BATE KENNETH	Director	Option Exercise	A	1.27	6,500	8,255	6,500
Jun 30 2017	SNTA	MADRIGAL PHARMACEU ...	BATE KENNETH	Director	Option Exercise	A	16.46	10,000	164,600	10,000
Jun 26 2017	EPZM	Epizyme, Inc.	BATE KENNETH	Director	Option Exercise	A	13.65	12,500	170,625	12,500
Jun 23 2017	AVEO	AVEO PHARMACEUTICA ...	BATE KENNETH	Director	Option Exercise	A	0.70	57,857	40,500	57,857
Jun 23 2017	AVEO	AVEO PHARMACEUTICA ...	BATE KENNETH	Director	Option Exercise	A	0.70	20,000	14,000	20,000
Jun 19 2017	VNDA	Vanda Pharmaceutic ...	BATE KENNETH	Director	Option Exercise	A	13.75	10,000	137,500	10,000
Jun 19 2017	VNDA	Vanda Pharmaceutic ...	BATE KENNETH	Director	Grant	A	0.00	5,000	0	5,000	0 to 5 K
Jun 15 2017	GNCA	GENOCEA BIOSCIENCE ...	BATE KENNETH	Director	Option Exercise	A	5.34	15,000	80,100	15,000
Oct 24 2016	SNTA	MADRIGAL PHARMACEU ...	BATE KENNETH	Director	Option Exercise	A	12.01	20,000	240,200	20,000
Aug 05 2016	CATB	CATABASIS PHARMACE ...	BATE KENNETH	Director	Option Exercise	A	4.55	6,500	29,575	6,500
Jun 09 2016	GNCA	GENOCEA BIOSCIENCE ...	BATE KENNETH	Director	Option Exercise	A	4.64	15,000	69,600	15,000
May 31 2016	AVEO	AVEO PHARMACEUTICA ...	BATE KENNETH	Director	Option Exercise	A	0.92	44,021	40,499	44,021
May 31 2016	AVEO	AVEO PHARMACEUTICA ...	BATE KENNETH	Director	Option Exercise	A	0.92	20,000	18,400	20,000
May 23 2016	EPZM	Epizyme, Inc.	BATE KENNETH	Director	Option Exercise	A	9.33	12,500	116,625	12,500
Dec 21 2015	VNDA	Vanda Pharmaceutic ...	BATE KENNETH	Director	Option Exercise	A	9.38	35,000	328,300	35,000
Jul 10 2015	EPZM	Epizyme, Inc.	BATE KENNETH	Director	Option Exercise	A	22.78	7,333	167,046	7,333
Jun 30 2015	CATB	CATABASIS PHARMACE ...	BATE KENNETH	Director	Option Exercise	A	12.21	11,094	135,458	11,094
Jun 18 2015	BMRN	BIOMARIN PHARMACEU ...	BATE KENNETH	Director	Option Exercise	A	122.27	3,300	403,491	3,300
Jun 18 2015	BMRN	BIOMARIN PHARMACEU ...	BATE KENNETH	Director	Grant	A	0.00	1,100	0	11,875	10.8 K to 11.9 K (+10.21 %)
Jun 01 2015	AVEO	AVEO PHARMACEUTICA ...	BATE KENNETH	Director	Option Exercise	A	2.00	20,000	40,000	20,000
Apr 06 2015	AVEO	AVEO PHARMACEUTICA ...	BATE KENNETH	Director	Option Exercise	A	1.61	25,155	40,500	25,155
Mar 02 2015	GNCA	GENOCEA BIOSCIENCE ...	BATE KENNETH	Director	Option Exercise	A	9.08	5,042	45,781	5,042
Sep 27 2004	MLNM	MILLENNIUM PHARMAC ...	BATE KENNETH	ExecVP; Head of Com ...	Option Exercise	A	13.36	125,000	1,670,000	125,000
Sep 02 2004	MLNM	MILLENNIUM PHARMAC ...	BATE KENNETH	ExecVP; Head of Com ...	Option Exercise	A	12.09	71,250	861,413	71,250
Feb 27 2004	MLNM	MILLENNIUM PHARMAC ...	BATE KENNETH	EVP; Chief Financia ...	Option Exercise	A	17.77	71,250	1,266,113	71,250

Page: 1